UK’s Medicines and Healthcare products Regulatory Agency (MHRA) and the US Food and Drug Administration (FDA) will enhance collaboration to accelerate innovation, strengthen patient safety, and reduce transatlantic barriers in medical technology and AI. This includes the launch of the MHRA’s National AI Commission, featuring experts from both countries, to guide the safe and transparent use of AI in healthcare. Additionally, new international reliance routes will facilitate faster UK market access for medical devices approved by trusted regulators, such as the FDA. These initiatives aim to harmonize regulations and expedite patient access to cutting-edge medical technologies.
Click here for the official article/release
Disclaimer
The Legal Wire takes all necessary precautions to ensure that the materials, information, and documents on its website, including but not limited to articles, newsletters, reports, and blogs (“Materials”), are accurate and complete. Nevertheless, these Materials are intended solely for general informational purposes and do not constitute legal advice. They may not necessarily reflect the current laws or regulations. The Materials should not be interpreted as legal advice on any specific matter. Furthermore, the content and interpretation of the Materials and the laws discussed within are subject to change.
